CGP Assays Prior to Initial Treatment Would Have Little Impact on Health Finances: Professor

Kyoto University Hospital Professor Manabu Muto Comprehensive genomic profiling (CGP) assays would only have a trivial impact on the overall medical expenditure in Japan even if they were used prior to initial cancer treatment under the coverage of public health...read more